Viewing StudyNCT04643483



Ignite Creation Date: 2024-05-06 @ 3:28 PM
Last Modification Date: 2024-10-26 @ 1:50 PM
Study NCT ID: NCT04643483
Status: WITHDRAWN
Last Update Posted: 2021-06-23
First Post: 2020-11-19

Brief Title: A Study to Test Efficacy Safety and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohns Disease
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-06
Start Date Type: ESTIMATED
Primary Completion Date: 2023-09
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-04
Completion Date Type: ESTIMATED
First Submit Date: 2020-11-19
First Submit QC Date: November 19 2020
Study First Post Date: 2020-11-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-06-17
Last Update Post Date: 2021-06-23
Last Update Post Date Type: ACTUAL